Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus

Key facts

Sponsor

University of California, San Francisco

Principal Investigator

Ronald Clyman, MD

University of California, San Francisco

Intervention

pharmacologic treatment of the PDA(other)

Enrollment

202 enrolled

Eligibility

All sexes

Timeline

2013 – 2017

Study locations (18)

• University of California San Diego, San Diego, California, United States
• Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, United States
• University of California San Francisco, San Francisco, California, United States
• Mednax Neonatology of San Jose/Pediatrix Medical Group, San Jose, California, United States
• Kaiser Permanente Santa Clara, Santa Clara, California, United States
• South Miami Hospital, Miami, Florida, United States
• University of Chicago Medicine, Chicago, Illinois, United States
• Northshore University Health System, Evanston, Illinois, United States
• Johns Hopkins University, Baltimore, Maryland, United States
• Mayo Clinic, Rochester, Minnesota, United States
• Morristown Medical Center, Morristown, New Jersey, United States
• Columbia University, New York, New York, United States
• Providence St Vincent Medical Center, Portland, Oregon, United States
• University Hospital, Umea, Sweden, Umeå, Sweden
• Ankara University School of Medicine Children's Hospital, Ankara, Turkey (Türkiye)
• +3 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Arterial duct anomaly

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNCT06950164
  Dynamic Changes of Ductus Arteriosus in < 31 Weeks Preterm Infants: an Observational Study
  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
• RECRUITINGNCT06658496
  PDA for Kidneys Study
  University of Wisconsin, Madison
• RECRUITINGNCT06646250
  NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
  St. Olavs Hospital
• RECRUITINGPHASE2NCT07143201
  Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT
  Hamilton Health Sciences Corporation
• RECRUITINGNCT05264753
  Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects
  Occlutech International AB
• ACTIVE NOT RECRUITINGNCT04371081
  Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance
  Abbott Medical Devices
• ENROLLING BY INVITATIONNANCT04667455
  Improving Care for Children With Congenital Heart Disease.
  Lund University Hospital
• ACTIVE NOT RECRUITINGNCT03782610
  Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
  Nationwide Children's Hospital

See all trials for Arterial duct anomaly →